Vitamin B6 (Pyridoxal 5′ Phosphate) antagonises carotid body P2X3 receptors in hypertension
Cardiovascular Research · 16.03.2026 · 122 (2) · 285-296
DOI: 10.1093/cvr/cvaf195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 16.10.2025. Verfasst von Igor S A Felippe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Manaaki Manawa-The Centre for Heart Research, Faculty of Medical & Health Sciences, University of Auckland, 85 Park Road, G…. Hauptthemen laut MEDLINE: Carotid Body, Pyridoxal Phosphate, Hypertension, Receptors, Purinergic P2X3. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Research Council Programme, Sidney Taylor Trust, Partridge Research Laureate award.
Abstract (Originalsprache)
Aims
ATP acting on P2X3 receptors (P2X3R) within carotid bodies (CBs) underpins chemoreflex-mediated sympathetic overactivity in spontaneously hypertensive rats (SHR). Pyridoxal 5′ phosphate (PLP), the active form of vitamin B6, has been reported to act as a non-selective P2X receptor blocker. Hence, we hypothesised that PLP antagonism of P2X3R in the CB would treat hypertension. Methods and results Herein, we employed a multipronged approach to investigate PLP’s capability to attenuate CB hyperexcitability in hypertension. First, PLP inhibited Ca2+ responses evoked by α, β-methylene ATP in cell lines expressing human (h) P2X3R with an IC50 of 8.7 µM. Next, in-silico data predicted that PLP binds to the same site of Gefapixant, supporting an allosteric antagonism. Using an isolated perfused carotid artery bifurcation-CB preparation, arterial infusion of PLP (50 µM; 15 min) attenuated CBs sensory firing in SHR (P = 0.012). Using the in situ working-heart brainstem preparation, carotid artery injections of PLP (1–5 mM) attenuated the chemoreflex-evoked sympathetic (P = 0.023) but not phrenic (P = 0.62) responses; the CB was stimulated with potassium cyanide (KCN,50 µL; 0.04%). In awake telemetered SHR (n = 6), intravenous infusion of PLP (48 mg/Kg/h; 30 min) attenuated KCN-evoked chemoreflex responses and reduced systolic, diastolic, and mean blood pressures (ΔMBP = −15.6 mmHg; P = 0.025). Translating our results, we performed a small double-blind, randomised clinical trial. In volunteers with hypertension (n = 14), oral supplementation with pyridoxine hydrochloride (600 mg) attenuated the hypoxic ventilatory response only in patients with high peripheral chemoreflex sensitivity (P = 0.021).
Conclusion
Our findings suggest that PLP binds to and antagonises P2X3R and is a viable candidate for larger clinical trials to treat CB dysregulation in cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Manaaki Manawa-The Centre for Heart Research, Faculty of Medical & Health Sciences, University of Auckland, 85 Park Road, Grafton, 1023, Auckland, New Zealand.
- School of Biological Sciences, University of East Anglia, Norwich, United Kingdom.
- Physiology, Pharmacology and Toxicology Division, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
- School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff CF10 3BN, United Kingdom.
- Department of Medicine, Faculty of Medical & Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Internal Medicine, Division of Haematology, Oncology, and Blood & Marrow Transplantation and Department of Paediatrics, Division of Neonatology, University of Iowa, Iowa City, USA.
ORCID-Profile: Igor S A Felippe, Fiona McBryde, Julian F R Paton
Förderung
- Health Research Council Programme
- Sidney Taylor Trust
- Partridge Research Laureate award
- Health Research Council
- Lotteries Grant Board
- New Zealand Heart Foundation
- Health Research Council Sir Charles Hercus Fellowship
- Ernest Hyam Davis & Ted & Mollie Carr Legacies
Zitieren
APA
Felippe, I. S. A., Babbage, T. L., Shaheen, R., Bassetto, M., Fan, J. L., Pauza, A., Gold, O., Thakkar, P., Dawes, M., Bates, M. L., McBryde, F., Fountain, S. J., Fisher, J. P., & Paton, J. F. R. (2026). Vitamin B6 (Pyridoxal 5′ Phosphate) antagonises carotid body P2X3 receptors in hypertension. Cardiovascular Research, 122(2), 285-296. https://doi.org/10.1093/cvr/cvaf195
Vancouver
Felippe ISA, Babbage TL, Shaheen R, Bassetto M, Fan JL, Pauza A, et al. Vitamin B6 (Pyridoxal 5′ Phosphate) antagonises carotid body P2X3 receptors in hypertension. Cardiovascular Research. 2026;122(2):285-296. doi:10.1093/cvr/cvaf195
BibTeX
@article{Felippe2026,
author = {Felippe, Igor S A and Babbage, Thalia L and Shaheen, Rajaa and Bassetto, Marcella and Fan, Jui-Lin and Pauza, Audrys and Gold, Olivia and Thakkar, Pratik and Dawes, Matthew and Bates, Melissa L and McBryde, Fiona and Fountain, Samuel J and Fisher, James P and Paton, Julian F R},
title = {Vitamin B6 (Pyridoxal 5′ Phosphate) antagonises carotid body P2X3 receptors in hypertension},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {2},
pages = {285--296},
doi = {10.1093/cvr/cvaf195}
}
EUVIMED